Melasma.
Conditions
Interventions
Intervention 1: Intervention group: Group A will be given 5% cysteamine at night. Intervention 2: Intervention group: Group B will be given 4% hydroquinone at night.
Sponsors
Cmh Quetta
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Adults aged 18-50 years with a clinical diagnosis of mild to moderate melasma (MASI score 4-24). Patients with Fitzpatrick skin types III to V . Patients with epidermal and dermal hyperpigmentation. Patients willing to use sun protection and adhere to treatment protocols.
Exclusion criteria
Exclusion criteria: Patients with chronic underlying diseases like eczema Pregnant and breastfeeding Patients allergic to cysteamine and hydroquinone
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in MASI score from baseline. Timepoint: Before intervention, 1 month,2 month and 3 month. Method of measurement: Photographic evidence and MASI score. | — |
Countries
Pakistan
Contacts
Public ContactSummra Pervaiz
Cmh Quetta
Outcome results
None listed